VAERS reports by lot

Pfizer Pneumococcal lot GL3699: VAERS reports

33 VAERS reports list lot GL3699 as a Pfizer Pneumococcal vaccine, received between 2023-02-02 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
12%
Marked serious
1
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3226%
General / Systemic (non-local)2621%
Neurological1210%
Cardiac / Cardiovascular1210%
Musculoskeletal1210%
Allergic / Anaphylactic108%
Gastrointestinal97%
Dermatological (non-injection-site)86%
Respiratory32%

Where reports came from

U.S. state of the reporter, where given (top 12).

California4
Washington4
New York3
Wisconsin2
Pennsylvania2
Michigan2
Oregon2
Colorado1
Nevada1
Georgia1
Iowa1
Idaho1

Reports by month received

2023-025
2023-0312
2023-044
2023-053
2023-061
2023-091
2023-102
2023-113
2023-121
2024-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.